Drug stocks gain in early action while shares of Cell Therapeutics bounced back after diving almost 25% on Monday over concerns about its new non-Hodgkin’s lymphoma treatment pixantrone. (source: Market Watch) – RSS feeds and Feed widget on Feedzilla.com

